Systemic effects of metformin

Abstract

Metformin is currently considered to be the first choice antidiabetic agent in patients with type 2 diabetes, which is also suitable for patients with prediabetic disorders.

Keywords

• Metformin
• cardiovascular effects
• reduction of cancer risk
• ovulation
• liver steatosis
• diabetic osteopathy